Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease caused by
the death of motor neurons. Riluzole is a benzothiazole derivative that blocks glutamatergic …

Objective To investigate the association between the use of common medications on
hypertension, hyperlipidemia, diabetes, and the risk of amyotrophic lateral sclerosis (ALS) …

Abstract Introduction/Aims Riluzole is a glutamate inhibitor approved for the treatment of
amyotrophic lateral sclerosis (ALS). There are scant data on factors associated with riluzole …

Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …

Introduction To date, riluzole and edaravone are the only two drugs that have successfully
passed clinical trials for the treatment of Amyotrophic Lateral Sclerosis (ALS). Unfortunately …

To test the hypothesis that aspirin, non-aspirin nonsteroidal anti-infammatory drugs (NA-
NSAIDs), or acetaminophen can reduce the risk of ALS, we conducted a systematic review …

Introduction Although rehabilitation is recommended for amyotrophic lateral sclerosis (ALS),
improvement of functional decline has hardly been achieved. We investigated the effect of …

Background The progression of many degenerative diseases is tracked periodically using
scales evaluating functionality in daily activities. Although estimating the timing of critical …

Disease‐modifying pharmacological treatments for amyotrophic lateral sclerosis/motor neuron
disease: an overview of intervention reviews - PMC Back to Top Skip to main content NIH NLM …

Continuity of treatment in ALS: Benefits and challenges of maintaining riluzole over the course
of the disease - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books …